Biotech Stocks Growth Stocks Healthcare Stocks Life Sciences Mid Cap Stocks Small Caps Stocks

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

ASX Biotech Investing has always been the market’s most difficult arena. Yes tech and resources are risky spaces too, but at least a gold explorer can gain just off the…

ByNick Sundich

27

Mar 2025

Healthcare Stocks

Opthea (ASX:OPT): It’s a tragedy to see the dream is (most likely) over after poor Phase 3 data

It has been a few years since investors have paid attention to biotech Opthea (ASX:OPT) on the scale that they have in the past week or so. Since its stellar…

ByNick Sundich

27

Dec 2024

Biotech Stocks Blue Chip Stocks Consumer Education ETF General Gold Stocks Growth Stocks Healthcare Stocks Industrials Large Caps Life Sciences Mining Stocks News Penny Stocks Resources Retail Safe Stocks Small Caps Stocks Tech Stocks Technology Undervalued Stocks Uranium Stocks

Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!

Here are our 6 Best ASX Stocks for 2025! Opthea (ASX:OPT) Its been a long wait, but 2025 will finally be the year Opthea (ASX:OPT) investors receive Phase 3 results.…

ByNick Sundich

01

Jul 2024

General Healthcare Stocks

What are the best ASX Health Stocks for FY25? Here are our top 4 picks!

As FY24 has come to an end, we thought we'd list our best ASX Health Stocks for FY25! Traditionally, healthcare stocks are seen as defensive plays in dour markets. This…

ByNick Sundich

26

Apr 2024

Uncategorized

5 ASX Health stocks to add to your porfolio

5 ASX Health Stocks Stuart Roberts from Stocks Down Under discussed the potential promise of biotech, sharing his perspectives about the industry's future amidst changing interest rates. He compares the…

ByMarc Kennis

22

Jan 2024

Uncategorized

FDA approval for ASX health stocks: Which companies are close to the green light in 2024?

FDA approval for ASX health stocks is the dream that just about all emerging companies in the sector are aspiring to. Just over 12 months ago, we predicted that Neuren…

ByNick Sundich

02

Jan 2024

Uncategorized

Here are our 4 predictions for the ASX in 2024 and why there’s cause for optimism about them

As the new calendar year begins, we thought we would share our top 4 predictions for the ASX in 2024. We hope all investors have a Happy New Year, although we…

ByNick Sundich

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

Opthea (ASX:OPT): It’s a tragedy to see the dream is (most likely) over after poor Phase 3 data

Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!

What are the best ASX Health Stocks for FY25? Here are our top 4 picks!

5 ASX Health stocks to add to your porfolio

FDA approval for ASX health stocks: Which companies are close to the green light in 2024?

Here are our 4 predictions for the ASX in 2024 and why there’s cause for optimism about them

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here